Montefiore researchers are continually testing new treatments for MDS, and many of these studies originate at the Albert Einstein College of Medicine. These investigational approaches are offered to eligible patients here through the clinical trial process, which is designed to advance the current standard of care for MDS.
By treating patients with MDS in clinical trials, physicians have shown that 5-azacytidine, Decitabine, and Lenalidomide are safe and effective treatments for MDS. These clinical trials led to FDA approval of these drugs, and in this same way, we hope to develop even better treatments for MDS.
As with all cancer treatment, clinical trials involve a team approach, in which physicians, scientists, and pathologists work together to care for each patient. We are experts at determining which patients will derive the most benefit from which trial.